Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 8, 2007, Pages 1226-1231

  Cho, Soo Jeong ^a   Yoon, Jung Hwan ^a   Hwang, Seung Sik ^b   Lee, Hyo Suk ^a  

^a Seoul National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

Author keywords

Hepatocellular carcinoma; Prognosis; Young age

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL STUDY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; FEMALE; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; SURVIVAL RATE; TUMOR GROWTH;

EID: 34547652164     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04914.x     Document Type: Article

References (39)

1. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992 15 : 948 63.
2. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004 127 : S5 S16.
3. Shiratori Y, Yoshida H, Omata M. Different clinicopathological features of hepatocellular carcinoma in relation to causative agents. J. Gastroenterol. 2001 36 : 73 8.
4. Kath R, Fiehler J, Schneider CP, Hoffken K. Gastric cancer in very young adults: apropos four patients and a review of the literature. J. Cancer Res. Clin. Oncol. 2000 126 : 233 7.
5. de la Monte SM, Hutchins GM, Moore GW. Influence of age on the metastatic behavior of breast carcinoma. Hum. Pathol. 1988 19 : 529 34.
6. Adami HO, Malker B, Holmberg L, Persson I, Stone B. The relation between survival and age at diagnosis in breast cancer. N. Engl. J. Med. 1986 315 : 559 63.
7. Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 1998 83 : 25 33.
8. Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn. J. Clin. Oncol. 1996 26 : 139 43.
9. Wang JY, Hsieh JS, Huang CJ, Huang YS, Huang TJ. Clinicopathologic study of advanced gastric cancer without serosal invasion in young and old patients. J. Surg. Oncol. 1996 63 : 36 40.
10. Lai IR, Lee WJ, Chen CN et al. Gastric cancer in the young. Hepatogastroenterology 1997 44 : 1641 5.
11. Bourke W, Milstein D, Giura R et al. Lung cancer in young adults. Chest 1992 102 : 1723 9.
12. Wan J, Grossman HB. Bladder carcinoma in patients age 40 years or younger. Cancer 1989 64 : 178 81.
13. Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann. Surg. Oncol. 1996 3 : 534 8.
14. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res. 1988 48 : 7314 18.
15. The Liver Cancer Study Group of Japan. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994 74 : 2772 80.
16. Yamanaka N, Okamoto E, Oriyama T et al. A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann. Surg. 1994 219 : 342 6.
17. Ni YH, Chang MH, Hsu HY et al. Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 1991 68 : 1737 41.
18. Lee CL, Ko YC. Survival and distribution pattern of childhood liver cancer in Taiwan. Eur. J. Cancer 1998 34 : 2064 7.
19. Lam CM, Chan AO, Ho P et al. Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening. Aliment. Pharmacol. Ther. 2004 19 : 771 7.
20. Ng IO, Ng MM, Lai EC, Fan ST. Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J. Surg. Oncol. 1996 61 : 134 7.
21. Lee HS, Han CJ, Kim CY. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer 1993 72 : 2564 7.
22. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J. Gastroenterol. 2003 38 : 207 15.
23. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998 28 : 751 5.
24. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 1999 19 : 329 38.
25. Tsai JF, Jeng JE, Ho MS et al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br. J. Cancer 1997 76 : 968 74.
26. Donato F, Boffetta P, Puoti M. A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int. J. Cancer 1998 75 : 347 54.
27. Tagger A, Donato F, Ribero ML et al. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study. Int. J. Cancer 1999 81 : 695 9.
28. Sutton FM, Russell NC, Guinee VF, Alpert E. Factors affecting the prognosis of primary liver carcinoma. J. Clin. Oncol. 1988 6 : 321 8.
29. Chlebowski RT, Tong M, Weissman J et al. Hepatocellular carcinoma. Diagnostic and prognostic features in North American patients. Cancer 1984 53 : 2701 6.
30. Calvet X, Bruix J, Gines P et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 1990 12 : 753 60.
31. Akashi Y, Koreeda C, Enomoto S et al. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 1991 14 : 262 8.
32. Okada S, Okazaki N, Nose H, Yoshimori M, Aoki K. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992 16 : 112 17.
33. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996 77 : 2217 22.
34. Prates MD. Cancer and cirrhosis of the liver in the Portuguese East African with special reference to the specific age and sex rates in Lourenco Marques. Acta Unio Int. Contra Cancrum 1961 17 : 718 39.
35. Kew MC, Rossouw E, Hodkinson J, Paterson A, Dusheiko GM, Whitcutt JM. Hepatitis B virus status of southern African Blacks with hepatocellular carcinoma: comparison between rural and urban patients. Hepatology 1983 3 : 65 8.
36. Kew MC, Houghton M, Choo QL, Kuo G. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990 335 : 873 4.
37. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 7 07 men in Taiwan. Lancet 1981 2 : 1129 33.
38. McMahon BJ, Bulkow L, Harpster A et al. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology 2000 32 : 842 6.
39. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2001 34 : 1225 41.